Br J Clin Pharmacol 2007;63:128-9. Szegedi A, Anghelescu I, Wiesner J, Schlegel S, Weigmann H, Härtter S, Eggert AE, Crismon ML, Dorson PG. Does the addition of a second antipsychotic drug improve clozapine treatment? [44] Expert Rev Neurother 2013;13:1-3. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.Things to remember when you fill your prescription.WebMD does not provide medical advice, diagnosis or treatment. Br J Psychiatry 2002;181:184-7. Tollefson GD, Birkett MA, Kiesler GM, Wood AJ; Lilly Resistant Schizophrenia Study Group. J Psychiatry Neurosci 2001;26:168. Pai NB, Laidlaw M, Vella SC. Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. It may increase the risk of suicide in those over the age of 20. Kossen M, Selten JP, Kahn RS. Leukocytosis after lithium and clozapine combination therapy. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder. Buchanan RW, Kirkpatrick B, Bryant N, Ball P, Breier A. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia. Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.
Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: A critical review. Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Weiner E, Conley RR, Ball MP, Feldman S, Gold JM, Kelly DL, Raskin S, Katz G, Zislin Z, Knobler HY, Durst R. Clozapine and risperidone: Combination/augmentation treatment of refractory schizophrenia: A preliminary observation. Saba G, Dumortier G, Kalalou K, Benadhira R, Degrassat K, Glikman J, Goff DC, Keefe R, Citrome L, Davy K, Krystal JH, Large C, Pavlovic ZM. Ann Clin Psychiatry 1998;10:113-5. Tseng KC, Hwang TJ. Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R. Increased dopamine d (2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. Zoccali R, Muscatello MR, Cedro C, Neri P, La Torre D, Spina E, Delle Chiaie R, Salviati M, Fiorentini S, Biondi M. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine. Am J Psychiatry 1994;151:1096-7. Schizophr Res 2009;110:80-9. Eur Neuropsychopharmacol 2012;22:165-82. Tiihonen J, Halonen P, Wahlbeck K, Repo-Tiihonen E, Hyvärinen S, Eronen M, Afshar H, Roohafza H, Mousavi G, Golchin S, Toghianifar N, Sadeghi M, Behdani F, Hebrani P, Rezaei Ardani A, Rafee E. Effect of topiramate augmentation in chronic schizophrenia: A placebo-controlled trial. Treatment resistance to what is often deemed the last line of schizophrenia treatment, clozapine, is a burgeoning problem in psychiatric practice, with estimates of clozapine resistance standing at 40–70% of the treated population. Med Hypotheses 2013;80:530-3. Zoccali R, Muscatello MR, Torre DL, Malara G, Canale A, Crucitti D, Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Goff DC, Leahy L, Berman I, Posever T, Herz L, Leon AC, Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY. Sudden cardiac death with clozapine and sertraline combination. Josiassen RC, Joseph A, Kohegyi E, et al. Int Clin Psychopharmacol 1998;13:19-21. Pharmacopsychiatry 1997;30:266-70. J Clin Psychiatry 2000;61:594-9. Since clomipramine can be toxic at higher serum levels, a serum level should be checked. Andrade C. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia. J Clin Psychiatry 1994;55:255-7. Dursun SM, Deakin JF. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Am J Psychiatry 1999;156:145-7. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. Psychiatr Q 2006;77:81-95. Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Rajarethinam R, Gilani S, Tancer M, DeQuardo J. Augmentation of clozapine partial responders with conventional antipsychotics. Masoudzadeh A, Khalilian AR. The Risperidone Study Group. Eur Psychiatry 2005;20:409-15. 11. Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Tharyan P, Adams CE. Am J Psychiatry 1996;153:1625-7. Schizophrenia: When clozapine fails. Indian J Psychiatry 2012;54:394. J Clin Psychopharmacol 2009;29:398-9. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. Biol Psychiatry 1996;40:1155-63.